Arab Finance: Memphis Pharmaceutical’s board approved the estimated budget for fiscal year (FY) 2025/2026, targeting net profits after tax valued at EGP 300 million, as per a bourse disclosure.

This is higher than the EGP 191.46 million net profits as of June 30^th, 2024.

The company also aims to generate revenues amounting to EGP 1.597 billion in FY 2025/26, compared to EGP 871.9 million in the previous FY.

In the first nine months of FY2024/25, Memphis recorded 125.9% year-on-year (YoY) higher net profits after tax at EGP 375.756 million, compared with EGP 166.368 million.

Qalaa Holdings to raise authorized capital to EGP 50B Updated 6/12/2025 9:51:00 AM

Memphis posts 125.9% YoY higher profits in 9 months Updated 4/28/2025 9:58:00 AM

Kima eyes achieving EGP 1.36B net profits in FY2025/26 Updated 4/17/2025 7:52:00 AM

Boursa Kuwait appoints Bader Nasser Al-Kharafi as Chairman Updated 3/26/2025 7:18:00 AM

QNB Egypt’s board approves EGP 1.5/share dividend Updated 2/23/2025 11:17:00 AM